STUDY SUMMARY
Adrenal gland Cancer Model: TM01087
NSG™ mice engrafted with passage 3 tumors for model TM01087
were randomly assigned to one of these treatment groups:
- 5% dextrose in water (vehicle control; 5 ml/kg IV once per week for three times; N=8)
- Cisplatin (2 mg/kg; IV once per week for three times; N=8)
- Cyclophosphamide (40 mg/kg; IV once per week for three times; N=8)
- Docetaxel (15 mg/kg; IV once per week for two times; N=8)
- Topotecan (2 mg/kg; PO for five days per week for three cycles; N=8)
Mice were monitored for tumor volume at least twice per week throughout the study period.
• Treatment groups
• Individual subjects / spider plot
• RECIST scores
• Waterfall plot
• TGI plot
• Protocols
Hide/show treatment groups
Hide/show treatment groups
Hide/show treatment groups